FDA Grants 'Breakthrough' Status To Novartis Muscle Drug, 'First Real Option …

FDA Grants 'Breakthrough' Status To Novartis Muscle Drug, 'First Real Option …

The FDA developed the “breakthrough therapy” designation to help expedite the development of drugs for life-threatening conditions. Novartis said the new designation will involve “more intensive FDA interaction and guidance” while developing the new

10
Like
Save

Comments

Write a comment

*